Kreft

EliteProspects founder Johan Nilsson has died at the age of 45 following a nine-year battle with colon cancer. The news was shared by the hockey database he created on Thursday. Nilsson, born in 1981, started the platform as a teenager.

10. mai 2026 Rapportert av AI Faktasjekket

Researchers reported at Digestive Disease Week (DDW) 2026 that older mice given fecal microbiota transplants made from their own preserved, younger-age stool samples showed less liver inflammation and injury—and none developed liver cancer in the experiment.

Preliminary research from USC Norris Comprehensive Cancer Center, presented at the American Association for Cancer Research (AACR) annual meeting, found that non-smokers diagnosed with lung cancer before age 50 reported eating more fruits, vegetables and whole grains—and had higher overall Healthy Eating Index scores—than the U.S. population average. The researchers emphasized that the results do not prove diet causes lung cancer and said a possible explanation could involve environmental exposures such as pesticides, a hypothesis that requires direct testing.

17. april 2026 Rapportert av AI

Tekur Anbesa Specialized Hospital in Addis Ababa has inaugurated a modern 27-bed cancer treatment center built at a cost of 6 million birr. The facility aims to enhance the quality of cancer and palliative care services, officials stated. Plans for prompt expansion of similar centers were announced.

Scientists at Johns Hopkins Medicine have pinpointed the gene KLF5 as a key driver of pancreatic cancer metastasis through epigenetic changes rather than DNA mutations. Using CRISPR technology, researchers found that KLF5 promotes tumor growth and invasion by altering DNA packaging and activating other cancer-related genes. The findings, published in Molecular Cancer, suggest potential new treatment targets.

5. april 2026 Rapportert av AI

Scientists at McMaster University and the Hospital for Sick Children in Canada have discovered that oligodendrocytes, cells typically supporting nerve function, aid the growth of glioblastoma by sending signals to tumor cells. Blocking this communication slowed tumor progression in lab models. The findings suggest an existing HIV drug, Maraviroc, could be repurposed for treatment.